Kinfo
Moolec Science SA logo

Moolec Science SA

MLECNASDAQHealthcare·US · USD
$8.09
+0.49 (+6.45%)
Close · 2026-06-29

Price

Key statistics

Valuation
Market cap5.87M USD
Enterprise value251.99M USD
Trailing P/E-0.03
Forward P/E-31.67
PEG ratio-0.00
Price / sales0.02
Price / book10.87
Profitability
Gross margin-25.52%
Operating margin-39.54%
Profit margin37.69%
Return on assets-22.61%
Return on equity55.85%
Income (TTM)
Revenue333.61M USD
Gross profit125.74M USD
EBITDA0.00 USD
Net income18.90M USD
Diluted EPS-$199.02
Rev. growth (YoY)69.75%
Balance sheet
Total cash1.04M USD
Total debt66.48M USD
Debt / equity4.38
Current ratio0.15
Book value / share$0.70
Cash flow (TTM)
Operating cash flow-34.65M USD
Levered free cash flow-46.28M USD
Shares & price
Shares outstanding725.57K
Float0.00
Held by institutions2.28%
Beta0.00
50-day MA$8.00
200-day MA$8.89
52-week high$100.20
52-week low$3.08
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-02-041.321.35+2.27%2025-11-180.250.33+32.00%2025-04-16-0.60-0.60+0.00%2025-01-31-0.70-0.50+28.57%2024-10-30-0.60-0.60+0.00%
About Moolec Science SA

Moolec Science SA is a science-based food ingredient company specializing in molecular farming technology to produce animal proteins, nutritional oils, and functional ingredients directly in plants and microbes. It develops innovative products such as Piggy Sooy, a soybean engineered to express porcine hemeproteins for enhanced taste, texture, and nutrition, and GLASO, a safflower oil enriched with gamma-linolenic acid for applications in pet food, human nutrition, and supplements. The company integrates molecular farming with precision fermentation to create sustainable solutions for food, pet food, animal feed, dietary supplements, and regenerative agriculture inputs. Through platforms like Mycofood for fungal-based proteins and ag-biologicals from associated brands, Moolec Science SA addresses needs in the food-tech and life sciences sectors. Operating across the United States, Europe, and South America, it supports the global food system with scalable, bio-based ingredients that combine crop efficiency with animal-like functionality. Founded in 2020 and headquartered in Luxembourg, Moolec Science SA drives advancements in sustainable ingredient production.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Gaston Paladini M.B.A.
Employees
52
Headquarters
Grand Cayman, Cayman Islands

Frequently asked questions about Moolec Science SA